European Journal of Internal Medicine最新文献

筛选
英文 中文
High-flow nasal oxygen therapy in patients with hypercapnic respiratory failure: A systematic review and meta-analysis.
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-02-08 DOI: 10.1016/j.ejim.2025.02.015
Lili Guan, Jianyi Niu, Qiaoyun Huang, Shanshan Zha, Zhenfeng He, Jieying Hu, Shengchuan Feng, Luqian Zhou, Rongchang Chen
{"title":"High-flow nasal oxygen therapy in patients with hypercapnic respiratory failure: A systematic review and meta-analysis.","authors":"Lili Guan, Jianyi Niu, Qiaoyun Huang, Shanshan Zha, Zhenfeng He, Jieying Hu, Shengchuan Feng, Luqian Zhou, Rongchang Chen","doi":"10.1016/j.ejim.2025.02.015","DOIUrl":"https://doi.org/10.1016/j.ejim.2025.02.015","url":null,"abstract":"<p><strong>Background: </strong>Noninvasive ventilation (NIV) is recommended as the first-line respiratory support method for patients with hypercapnic respiratory failure (HRF). However, the need for well-trained operators and the occurrence of treatment discomfort may limit its efficacy. High-flow nasal oxygen therapy (HFNO) is a convenient respiratory support with user-friendly operation, high comfort, and good compliance. This systematic review and meta-analysis was performed to compare the therapeutic effects of HFNO and other noninvasive respiratory support methods [NIV or conventional oxygen therapy (COT)] in patients with acute HRF (AHRF) or chronic HRF (CHRF).</p><p><strong>Methods: </strong>We searched the PubMed, Web of Science, Embase, and Cochrane Library databases from inception to May 2024 to identify randomized clinical trials comparing the impact of HFNO and NIV/COT in adults with HRF.</p><p><strong>Results: </strong>Sixteen studies (1630 patients) were included. Compared with NIV, HFNO did not improve the primary outcome of PaCO<sub>2</sub> in patients with AHRF or CHRF [AHRF: MD = -0.81, 95 % CI = -3.40 to 1.77; CHRF: MD = 1.82, 95 % CI = 0.44 to 3.20]. However, HFNO showed advantages over COT (AHRF: MD = -2.03, 95 % CI = -3.48 to -0.59; CHRF: MD = -2.64, 95 % CI = -4.24 to -1.03).</p><p><strong>Conclusions: </strong>The evidence of its clinical efficacy in hypercapnic patients remains inconclusive. Further studies are needed to generate more evidence for the application of HFNO in patients with HRF and to determine the subset of patients for whom may be preferable.</p>","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143384064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rising ischemic stroke-related mortality among young adults in the United States: Insights from CDC WONDER.
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-02-08 DOI: 10.1016/j.ejim.2025.02.008
Usama Qamar, Farhan Naeem, Maaz Asif, Waleed Qamar, Eisha Mazhar
{"title":"Rising ischemic stroke-related mortality among young adults in the United States: Insights from CDC WONDER.","authors":"Usama Qamar, Farhan Naeem, Maaz Asif, Waleed Qamar, Eisha Mazhar","doi":"10.1016/j.ejim.2025.02.008","DOIUrl":"https://doi.org/10.1016/j.ejim.2025.02.008","url":null,"abstract":"","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143384070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reevaluating hypoxia and cancer as determinants of prognosis in COPD and Takotsubo syndrome. Author's reply.
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-02-08 DOI: 10.1016/j.ejim.2025.02.012
Luca Arcari, Giacomo Tini, Beatrice Musumeci, Emanuele Barbato, Luca Cacciotti
{"title":"Reevaluating hypoxia and cancer as determinants of prognosis in COPD and Takotsubo syndrome. Author's reply.","authors":"Luca Arcari, Giacomo Tini, Beatrice Musumeci, Emanuele Barbato, Luca Cacciotti","doi":"10.1016/j.ejim.2025.02.012","DOIUrl":"https://doi.org/10.1016/j.ejim.2025.02.012","url":null,"abstract":"","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143384067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bedside CEUS: A feasible option to consider.
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-02-06 DOI: 10.1016/j.ejim.2025.02.001
Andrea Boccatonda, Alice Brighenti, Valeria Tiraferri, Rossella Loiacono, Carla Serra
{"title":"Bedside CEUS: A feasible option to consider.","authors":"Andrea Boccatonda, Alice Brighenti, Valeria Tiraferri, Rossella Loiacono, Carla Serra","doi":"10.1016/j.ejim.2025.02.001","DOIUrl":"https://doi.org/10.1016/j.ejim.2025.02.001","url":null,"abstract":"","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143371131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refining risk assessment for intra-abdominal infections in immunocompromised intensive care unit patients. Author's reply.
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-02-06 DOI: 10.1016/j.ejim.2025.02.005
Stijn Blot, Mieke Deschepper, José Artur Paiva
{"title":"Refining risk assessment for intra-abdominal infections in immunocompromised intensive care unit patients. Author's reply.","authors":"Stijn Blot, Mieke Deschepper, José Artur Paiva","doi":"10.1016/j.ejim.2025.02.005","DOIUrl":"https://doi.org/10.1016/j.ejim.2025.02.005","url":null,"abstract":"","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143371134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bridging the gap: Time to integrate sex and gender differences into research and clinical practice for improved health outcomes.
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-02-05 DOI: 10.1016/j.ejim.2025.01.030
Roberta Gualtierotti
{"title":"Bridging the gap: Time to integrate sex and gender differences into research and clinical practice for improved health outcomes.","authors":"Roberta Gualtierotti","doi":"10.1016/j.ejim.2025.01.030","DOIUrl":"https://doi.org/10.1016/j.ejim.2025.01.030","url":null,"abstract":"<p><p>The integration of sex and gender in medical research and clinical practice is increasingly recognized as a cornerstone for achieving equitable health outcomes. Biological sex and gender influence the manifestation, progression, and treatment response in numerous diseases. Biological sex influences health and disease outcomes through genetic, hormonal, and physiological factors, while gender impacts them via identity, societal roles and behaviors. Historically, medical research has focused predominantly on the male body, leading to diagnostic and therapeutic gaps for women and gender-diverse populations. In particular, women remain underrepresented in clinical trials, leading to suboptimal treatment strategies and outcomes. In addition, in many conditions, such as cardiovascular, metabolic and neurological diseases, sex-specific variations in risk factors and disease presentation are prominent. The present review discusses the critical importance of distinguishing between sex and gender in preclinical and clinical research, and the necessity of incorporating these variables across all stages of research, from study design to analysis and reporting of preclinical studies and clinical trials. By incorporating sex and gender as distinct but interacting variables, we propose a framework to advance health equity and foster personalized, inclusive healthcare. This approach will promote the development of gender-sensitive clinical guidelines, enhance the accuracy of diagnostic tools, and ultimately contribute to improved health outcomes for all individuals, regardless of their sex or gender identity.</p>","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143365916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disability and caregivers in Italy: Results from an online survey. 意大利的残疾与护理人员:在线调查结果。
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-02-03 DOI: 10.1016/j.ejim.2025.01.029
Sergio Harari, Antonella Caminati, Luigi Ripamonti, Paolo Marveggio, Pier Mannuccio Mannucci
{"title":"Disability and caregivers in Italy: Results from an online survey.","authors":"Sergio Harari, Antonella Caminati, Luigi Ripamonti, Paolo Marveggio, Pier Mannuccio Mannucci","doi":"10.1016/j.ejim.2025.01.029","DOIUrl":"https://doi.org/10.1016/j.ejim.2025.01.029","url":null,"abstract":"","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143191203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tecovirimat and mpox: A regulatory balancing act between hope, hurdles, and high-risk populations.
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-02-03 DOI: 10.1016/j.ejim.2025.01.031
John G Rizk, Giuseppe Lippi, Brandon M Henry, Kin Israel Notarte, Youssef Rizk
{"title":"Tecovirimat and mpox: A regulatory balancing act between hope, hurdles, and high-risk populations.","authors":"John G Rizk, Giuseppe Lippi, Brandon M Henry, Kin Israel Notarte, Youssef Rizk","doi":"10.1016/j.ejim.2025.01.031","DOIUrl":"https://doi.org/10.1016/j.ejim.2025.01.031","url":null,"abstract":"","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143191208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Linear lesions on the chest.
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-02-03 DOI: 10.1016/j.ejim.2025.01.023
Pei-Chun Weng, Pei-Rong Gao
{"title":"Linear lesions on the chest.","authors":"Pei-Chun Weng, Pei-Rong Gao","doi":"10.1016/j.ejim.2025.01.023","DOIUrl":"https://doi.org/10.1016/j.ejim.2025.01.023","url":null,"abstract":"","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143191206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
External validation of a prognostic score to identify low-risk outpatients with acute deep venous thrombosis in the lower limbs 外部验证用于识别急性下肢深静脉血栓低风险门诊患者的预后评分。
IF 5.9 2区 医学
European Journal of Internal Medicine Pub Date : 2025-02-01 DOI: 10.1016/j.ejim.2024.10.007
Francisco Galeano-Valle , Rubén Alonso-Beato , Sergio Moragón-Ledesma , Tatiana Pire-García , Olaya Huergo-Fernández , Lucía Ordieres-Ortega , Crhistian-Mario Oblitas , Luis Antonio Alvarez-Sala Walther , Pablo Demelo-Rodríguez
{"title":"External validation of a prognostic score to identify low-risk outpatients with acute deep venous thrombosis in the lower limbs","authors":"Francisco Galeano-Valle ,&nbsp;Rubén Alonso-Beato ,&nbsp;Sergio Moragón-Ledesma ,&nbsp;Tatiana Pire-García ,&nbsp;Olaya Huergo-Fernández ,&nbsp;Lucía Ordieres-Ortega ,&nbsp;Crhistian-Mario Oblitas ,&nbsp;Luis Antonio Alvarez-Sala Walther ,&nbsp;Pablo Demelo-Rodríguez","doi":"10.1016/j.ejim.2024.10.007","DOIUrl":"10.1016/j.ejim.2024.10.007","url":null,"abstract":"<div><h3>Background</h3><div>Current clinical guidelines suggest home treatment for patients diagnosed with acute deep venous thrombosis (DVT). A prognostic score has been proposed to identify low-risk patients; however, its validation remains limited.</div></div><div><h3>Method</h3><div>This prospective observational study aimed to externally validate the prognostic score in selecting low-risk outpatients with acute DVT in the lower limbs. Consecutive outpatients diagnosed with acute DVT in a tertiary hospital were included. The score included 6 variables: heart failure, kidney failure, recent major bleeding, altered platelet count, immobilization, and cancer. The primary outcome was the incidence of a composite outcome, including confirmed diagnosis of PE, major bleeding, or all-cause death at 7 days. Patients meeting zero criteria were considered low risk.</div></div><div><h3>Results</h3><div>Among the 1035 patients included, 485 (46.9 %) met zero criteria. Of these, 0.2 % (95 % CI 0.0–1.1 %) and 0.4 % (95 % CI, 0.0–1.5 %) patients experienced the composite outcome at 7 and 30 days, respectively. Among patients who met 1 or more criteria for admission, 344 patients (62.5 %) were discharged. Among these, the composite outcome at 7 and 30 days occurred in 2 (0.6 %) and 5 (1.4 %) patients, respectively. The C-statistics of the score were 0.68 (95 % CI, 0.57–0.79) and 0.69 (95 % CI, 0.64–0.76) at 7 and 30 days, respectively.</div></div><div><h3>Conclusion</h3><div>This study demonstrates the efficacy of the prognostic score in identifying low-risk outpatients with acute DVT. It also suggests that a considerable proportion of patients with acute DVT may benefit from outpatient treatment despite having some risk criteria, highlighting the potential for optimizing ambulatory care pathways.</div></div>","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":"132 ","pages":"Pages 76-83"},"PeriodicalIF":5.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142479685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信